Adoption of Innovative Therapies Across Oncology Practices-Evidence From Immunotherapy.

ABSTRACT:

Importance

Immunotherapies reflect an important breakthrough in cancer treatment, substantially improving outcomes for patients with a variety of cancer types, yet little is known about which practices have adopted this novel therapy or the pace of adoption.

Objective

To assess adoption of immunotherapies across US oncology practices and examine variation in adoption by practice type.

Design, setting, and participants

This cohort study used data from Medicare fee-for-service beneficiaries undergoing 6-month chemotherapy episodes between 2010 and 2017. Data were analyzed January 19, 2021, to September 28, 2022, for patients with cancer types for which immunotherapy was approved by the US Food and Drug Administration (FDA) during the study period: melanoma, kidney cance

SUBMITTER: Carroll CE 

PROVIDER: S-EPMC9857528 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature